glp-1 multiple sclerosis Receptor Agonist Use Associated With Greater Physical Activity and Improved Patient-Reported Outcomes in Glucagon-like peptide-1 agonist safety and
Description
Showering is fine immediately after injection
Methods Study design
Scientists developed GLP-1 agonists as an alternative way for certain diabetic patients to control their blood sugar
Following an 8 h fast, rats received an intraperitoneal injection of sodium pyruvate (2 g/kg body weight) for the measurement of plasma pyruvate levels using an enzymatic assay
doi: 10.1016/j.diabres.2019.107927 111 AhmadASabbourH
This finding may relate to the different abilities of these agonists to target brain regions that are crucial for memory processes (Salinas et al., 2018)
